Xcout Intel
リニカル
Linical Co., Ltd., a global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.
Subscribe to see リニカル’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
リニカル at a glance
リニカル is a pharmaceuticals company headquartered in Osaka, Japan. It is publicly listed (2183) with a market capitalisation of $29.2M. Xcout tracks 8 named people at リニカル, including Clareece West (President and Chief Commercial Officer).
リニカル leadership
- Clareece WestPresident and Chief Commercial Officer
- Rebecca LambornChief Financial Officer（CFO）
- Miguel UrrutiaChief Information Officer（CIO）, Chief Information Security Officer（CISO）
- Tracy GoekenChief Medical Officer
- Tyler CochranChief Compliance Officer (CCO)
- Eun Kyung Anリニカル韓国 代表取締役社長
2 more named people on record for リニカル, with roles, board committees and tenure — see the full roster →
リニカル competitors
A few of リニカル's closest competitors — see the full list of competitors and alternatives →
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Hangzhou Tigermed Consulting Co., Ltd. operates as a contract research organization (CRO) providing clinical trial and research services for pharmaceutical, biotechnology, and medical device companies. The company supports clients throughout the product development lifecycle, offering services such as preclinical development, clinical monitoring, regulatory affairs, data management, and medical device trials.
Shanghai Medicilon Inc. is a contract research organization (CRO) that provides comprehensive drug discovery, chemistry, biology, CMC development, and preclinical research services. The company serves pharmaceutical and biotechnology innovators by offering integrated solutions spanning chemical synthesis, pharmacology, ADME/DMPK, and safety assessment to advance drug candidates toward IND filings.
ICON plc is a clinical research organization (CRO) that provides outsourced clinical, consulting, and commercial services to pharmaceutical, biotechnology, medical device, and government organizations. The company assists clients with drug development, clinical trials, laboratory services, regulatory affairs, and market access strategies.
C&R Research Inc. is a contract research organization (CRO) headquartered in Seoul, Republic of Korea. The company specializes in clinical trial design and provides services related to clinical trial quotations within the pharmaceutical manufacturing industry.
KCAS Bio (operating through Flowmetric Life Sciences, Inc.) provides conventional and spectral flow cytometry services, cell sorting, and biomarker testing to support non-clinical and clinical drug development studies. The company serves pharmaceutical and biotechnology sponsors by offering GLP/GCP-compliant bioanalytical services, including cellular phenotyping and immunogenicity assays, to advance clinical research programs.
Get リニカル's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about リニカル? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on リニカル in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access